Filed: 5/13/2026ACC: 0000904454-26-000280
📋 What this filing means
JOHNSON & JOHNSON filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $652.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$652.36M
Total AUM (reported)
30.28M
Total Shares
Allocation by class
COM$436.86M67.0%
SPONSORED ADS$188.34M28.9%
CL A$25.85M4.0%
COM NEW$1.11M0.2%
ORD SHS$189.7K0.0%
Portfolio Concentration
Top 3$489.26M75.0%
4–10$156.53M24.0%
11–25$6.57M1.0%
Top 3 weight
75.0%
Top 10 weight
99.0%
Voting Authority Distribution
Total shares with voting rights: 30.28M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
30.28M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other16
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings16
Rows:
Protagonist Therapeutics Inc.
DFNDShares2.45M
TypeSH
Market value$258.14M
39.57%
Sole
0.00
Shared
2.45M
None
0.00
Nanobiotix S.A.
DFNDShares5.62M
TypeSH
Market value$173.61M
26.61%
Sole
0.00
Shared
5.62M
None
0.00
MeiraGTx Holdings plc
DFNDShares6.64M
TypeSH
Market value$57.51M
8.82%
Sole
0.00
Shared
6.64M
None
0.00
Rapport Therapeutics, Inc.
DFNDShares1.78M
TypeSH
Market value$55.84M
8.56%
Sole
0.00
Shared
1.78M
None
0.00
CVRx, Inc.
DFNDShares4.02M
TypeSH
Market value$38.08M
5.84%
Sole
0.00
Shared
4.02M
None
0.00
Contineum Therapeutics Inc.
DFNDShares1.98M
TypeSH
Market value$25.85M
3.96%
Sole
0.00
Shared
1.98M
None
0.00
Legend Biotech Corporation
DFNDShares814.59K
TypeSH
Market value$14.74M
2.26%
Sole
0.00
Shared
814.59K
None
0.00
Xencor, Inc.
DFNDShares748.06K
TypeSH
Market value$9.02M
1.38%
Sole
0.00
Shared
748.06K
None
0.00
Procept BioRobotics Corporation
DFNDShares357.94K
TypeSH
Market value$8.95M
1.37%
Sole
0.00
Shared
357.94K
None
0.00
Fate Therapeutics, Inc.
DFNDShares3.38M
TypeSH
Market value$4.05M
0.62%
Sole
0.00
Shared
3.38M
None
0.00
Neumora Therapeutics, Inc.
DFNDShares1.85M
TypeSH
Market value$3.61M
0.55%
Sole
0.00
Shared
1.85M
None
0.00
Rallybio Corporation
DFNDShares152.90K
TypeSH
Market value$1.37M
0.21%
Sole
0.00
Shared
152.90K
None
0.00
Vor Biopharma, Inc.
DFNDShares53.73K
TypeSH
Market value$958.6K
0.15%
Sole
0.00
Shared
53.73K
None
0.00
Standard BioTools, Inc.
DFNDShares311.97K
TypeSH
Market value$286.8K
0.04%
Sole
0.00
Shared
311.97K
None
0.00
Nano-X Imaging Ltd.
DFNDShares83.55K
TypeSH
Market value$189.7K
0.03%
Sole
0.00
Shared
83.55K
None
0.00
Adicet Bio, Inc.
DFNDShares22.78K
TypeSH
Market value$155.1K
0.02%
Sole
0.00
Shared
22.78K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Protagonist Therapeutics Inc.DFND | COM | 2.45M | SH | $258.14M 39.57% | 0.00 | 2.45M | 0.00 |
Nanobiotix S.A.DFND | SPONSORED ADS | 5.62M | SH | $173.61M 26.61% | 0.00 | 5.62M | 0.00 |
MeiraGTx Holdings plcDFND | COM | 6.64M | SH | $57.51M 8.82% | 0.00 | 6.64M | 0.00 |
Rapport Therapeutics, Inc.DFND | COM | 1.78M | SH | $55.84M 8.56% | 0.00 | 1.78M | 0.00 |
CVRx, Inc.DFND | COM | 4.02M | SH | $38.08M 5.84% | 0.00 | 4.02M | 0.00 |
Contineum Therapeutics Inc.DFND | CL A | 1.98M | SH | $25.85M 3.96% | 0.00 | 1.98M | 0.00 |
Legend Biotech CorporationDFND | SPONSORED ADS | 814.59K | SH | $14.74M 2.26% | 0.00 | 814.59K | 0.00 |
Xencor, Inc.DFND | COM | 748.06K | SH | $9.02M 1.38% | 0.00 | 748.06K | 0.00 |
Procept BioRobotics CorporationDFND | COM | 357.94K | SH | $8.95M 1.37% | 0.00 | 357.94K | 0.00 |
Fate Therapeutics, Inc.DFND | COM | 3.38M | SH | $4.05M 0.62% | 0.00 | 3.38M | 0.00 |
Neumora Therapeutics, Inc.DFND | COM | 1.85M | SH | $3.61M 0.55% | 0.00 | 1.85M | 0.00 |
Rallybio CorporationDFND | COM | 152.90K | SH | $1.37M 0.21% | 0.00 | 152.90K | 0.00 |
Vor Biopharma, Inc.DFND | COM NEW | 53.73K | SH | $958.6K 0.15% | 0.00 | 53.73K | 0.00 |
Standard BioTools, Inc.DFND | COM | 311.97K | SH | $286.8K 0.04% | 0.00 | 311.97K | 0.00 |
Nano-X Imaging Ltd.DFND | ORD SHS | 83.55K | SH | $189.7K 0.03% | 0.00 | 83.55K | 0.00 |
Adicet Bio, Inc.DFND | COM NEW | 22.78K | SH | $155.1K 0.02% | 0.00 | 22.78K | 0.00 |